Cash flow Mitsui Fudosan Co., Ltd.

Equities

8801

JP3893200000

Real Estate Development & Operations

Market Closed - Japan Exchange Other stock markets 06:30:00 21/01/2026 GMT			5-day change	1st Jan Change
1,781.00 ^JPY	-1.90%		-5.32%	+0.03%

01-17	Mitsui Fudosan to invest $2.84 billion in rental housing development in the southern U.S. by fiscal 2030 - Nikkei	RE
01-06	Nippon Building Fund Inc. agreed to acquire an additional 9.19% stake in Toyosu Bayside Cross Tower from Mitsui Fudosan Co., Ltd. for ¥14.8 billion.	CI

96baca124afb11a4.DytHXquoLjOwVxsoilvOXC5ZHbLhpYxq2qFuMkFzx0w.bl8lHcb4V1nSejZ7um-_EW86d-uA99Y-qMsPWTkKsy42Tj1r_Pkcceg1cA

Published financial data: MITSUI FUDOSAN CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,008B	2,101B	2,269B	2,383B	2,625B
Total Revenues	2,008B	2,101B	2,269B	2,383B	2,625B
Cost of Goods Sold, Total	1,610B	1,650B	1,742B	1,790B	1,990B
Gross Profit	398B	450B	527B	593B	635B
Selling General & Admin Expenses, Total	193B	204B	221B	253B	262B
R&D Expenses	741M	1.29B	-	-	-
Other Operating Expenses, Total	194B	205B	221B	253B	262B
Operating Income	204B	245B	305B	340B	373B
Interest Expense, Total	-27.78B	-31.61B	-55.46B	-74.54B	-82.35B
Interest And Investment Income	6.88B	7.41B	8.48B	9.63B	11.77B
Net Interest Expenses	-20.9B	-24.2B	-46.98B	-64.9B	-70.58B
Income (Loss) On Equity Invest.	-6.16B	2.16B	7.32B	3.97B	-2.47B
Currency Exchange Gains (Loss)	-	-	-	2.66B	2.14B
Other Non Operating Income (Expenses)	-7.85B	2B	-396M	-13.53B	-11.57B
EBT, Excl. Unusual Items	169B	225B	265B	268B	290B
Gain (Loss) On Sale Of Investments	56.63B	51.73B	40.94B	54.12B	54.5B
Gain (Loss) On Sale Of Assets	20.7B	6.88B	-8.2B	4.43B	29.19B
Asset Writedown	-39.65B	-16.92B	-	-	-10.89B
Other Unusual Items	-14.73B	-4.22B	-2.17B	7.62B	1M
EBT, Incl. Unusual Items	192B	262B	296B	334B	363B
Income Tax Expense	62.09B	86.65B	92.56B	106B	117B
Earnings From Continuing Operations	130B	176B	203B	228B	246B
Net Income to Company	130B	176B	203B	228B	246B
Minority Interest	-151M	1.23B	-6.38B	-3.04B	2.73B
Net Income - (IS)	130B	177B	197B	225B	249B
Net Income to Common Incl Extra Items	130B	177B	197B	225B	249B
Net Income to Common Excl. Extra Items	130B	177B	197B	225B	249B
Per Share Items
Net EPS - Basic	44.81	61.48	69.3	80.19	89.26
Basic EPS - Continuing Operations	44.81	61.48	69.3	80.19	89.26
Basic Weighted Average Shares Outstanding	2.89B	2.88B	2.84B	2.8B	2.79B
Net EPS - Diluted	44.78	61.43	69.27	80.14	89.22
Diluted EPS - Continuing Operations	44.78	61.43	69.27	80.14	89.22
Diluted Weighted Average Shares Outstanding	2.89B	2.88B	2.84B	2.8B	2.79B
Normalized Basic EPS	36.45	49.26	56.1	58.68	66.07
Normalized Diluted EPS	36.42	49.23	56.07	58.64	66.04
Dividend Per Share	14.67	-	20.67	28	31
Payout Ratio	32.82	23.92	30.38	27.84	35.18
American Depositary Receipts Ratio (ADR)	3	3	3	3	3
Supplemental Items
EBITDA	302B	356B	431B	473B	513B
EBITA	204B	245B	305B	340B	373B
EBIT	204B	245B	305B	340B	373B
Effective Tax Rate - (Ratio)	32.37	33.02	31.28	31.84	32.22
Total Current Taxes	-	-	90.79B	-	-
Total Deferred Taxes	-	-	1.76B	-	-
Normalized Net Income	105B	142B	159B	164B	184B
Non-Cash Pension Expense	-1.4B	-3.63B	-7.12B	-9.21B	-7.9B
Supplemental Operating Expense Items
Advertising Expense	18.07B	17.01B	-	17.02B	22.11B
Selling and Marketing Expenses	18.07B	17.01B	-	17.02B	22.11B
Research And Development Expense From Footnotes	741M	1.29B	-	1.02B	1.08B
Stock-Based Comp., COGS (Total)	-	-	384M	-	-
Stock-Based Comp., SG&A Exp. (Total)	-	-	334M	-	-
Total Stock-Based Compensation	-	-	718M	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	190B	146B	132B	184B	164B
Short Term Investments	87M	99M	11.95B	91M	60M
Total Cash And Short Term Investments	190B	146B	144B	184B	164B
Accounts Receivable, Total	50.81B	70.46B	70.49B	81.13B	83.07B
Notes Receivable	17.19B	16.95B	16.89B	13.76B	9.4B
Total Receivables	67.99B	87.41B	87.38B	94.89B	92.47B
Inventory	1,939B	2,048B	2,160B	2,368B	2,498B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	260B	286B	356B	392B	414B
Total Current Assets	2,456B	2,568B	2,748B	3,039B	3,168B
Gross Property Plant And Equipment	-	-	5,491B	-	-
Accumulated Depreciation	-	-	-1,236B	-	-
Net Property Plant And Equipment	3,717B	3,842B	4,255B	4,300B	4,584B
Long-term Investments	1,454B	1,692B	1,258B	2,005B	1,914B
Other Intangibles, Total	79.63B	72.31B	38.34B	105B	123B
Loans Receivable Long-Term	8.86B	8.3B	8.94B	13.9B	37.07B
Deferred Tax Assets Long-Term	26.59B	25.59B	26.46B	25.82B	32.52B
Other Long-Term Assets, Total	3M	1M	507B	2M	1M
Total Assets	7,742B	8,208B	8,841B	9,490B	9,860B
Liabilities
Accounts Payable, Total	97.97B	135B	148B	131B	197B
Accrued Expenses, Total	-	-	73.03B	-	-
Short-term Borrowings	406B	533B	231B	614B	748B
Current Portion of Long-Term Debt	56.68B	108B	572B	79.8B	83.1B
Current Income Taxes Payable	50.34B	59.59B	41.63B	63.54B	75.69B
Unearned Revenue Current, Total	21.57B	-	178B	-	-
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	368B	441B	258B	551B	746B
Total Current Liabilities	1,001B	1,277B	1,502B	1,440B	1,850B
Long-Term Debt	3,160B	3,026B	3,246B	3,736B	3,585B
Pension & Other Post Retirement Benefits	48.91B	50.64B	46.47B	39.66B	35.67B
Deferred Tax Liability Non Current	364B	390B	378B	387B	330B
Other Non Current Liabilities	511B	550B	638B	652B	789B
Total Liabilities	5,086B	5,294B	5,810B	6,255B	6,589B
Common Stock, Total	340B	340B	341B	341B	342B
Additional Paid In Capital	372B	372B	367B	311B	314B
Retained Earnings	1,260B	1,391B	1,500B	1,659B	1,782B
Treasury Stock	-5.92B	-21.58B	-38.35B	-7.26B	-12.21B
Comprehensive Income and Other	591B	716B	734B	807B	722B
Total Common Equity	2,557B	2,798B	2,902B	3,111B	3,147B
Minority Interest	98.68B	116B	129B	124B	123B
Total Equity	2,656B	2,914B	3,031B	3,235B	3,271B
Total Liabilities And Equity	7,742B	8,208B	8,841B	9,490B	9,860B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.89B	2.85B	2.8B	2.8B	2.77B
ECS Total Common Shares Outstanding	2.89B	-	2.8B	2.8B	2.77B
Book Value / Share	885.97	981.17	1.04K	1.11K	1.14K
Tangible Book Value	2,478B	2,726B	2,864B	3,006B	3,024B
Tangible Book Value Per Share	858.38	955.81	1.02K	1.07K	1.09K
Total Debt	3,623B	3,667B	4,049B	4,430B	4,416B
Net Debt	3,434B	3,521B	3,904B	4,246B	4,252B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-2.61B	-15.22B	-19.08B	-46.34B	-46.36B
Minority Interest, Total (Incl. Fin. Div)	98.68B	116B	129B	124B	123B
Equity Method Investments, Total	-	-	443B	-	-
Account Code - Inventory Valuation	-	-	3	-	-
Inventories - Raw Materials, Total	301B	307B	306B	399B	547B
Inventories - Work In Process, Total	555B	549B	576B	562B	474B
Inventories - Finished Goods, Total	1,083B	1,192B	1,268B	1,407B	1,478B
Inventories - Others	-	-	10.74B	-	-
Land - (BS)	-	-	2,219B	-	-
Buildings, Total	-	-	2,700B	-	-
Machinery, Total	-	-	469B	-	-
Full Time Employees	23.99K	24.41K	-	25.59K	26.63K
Accumulated Allowance for Doubtful Accounts (Supple)	574M	810M	731M	1.99B	1.43B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	192B	262B	197B	334B	363B
Depreciation & Amortization - CF	98.2B	112B	125B	134B	141B
Depreciation & Amortization, Total	98.2B	112B	125B	134B	141B
(Gain) Loss From Sale Of Asset	18.94B	10.04B	8.2B	-4.43B	-18.29B
(Gain) Loss on Sale of Investments - (CF)	-56.63B	-51.73B	-40.94B	-54.12B	-54.5B
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	6.16B	-2.16B	-7.32B	-3.97B	2.47B
Other Operating Activities, Total	-86.06B	-84.98B	16.42B	-84.3B	-88.88B
Change In Accounts Receivable	-507M	-13.69B	-9.25B	-5.77B	1.07B
Change In Inventories	-4.64B	-26.38B	-170M	-194B	40.3B
Change In Accounts Payable	-7.75B	8.37B	8.48B	6.3B	9.41B
Change in Other Net Operating Assets	28.33B	58.1B	-	114B	204B
Cash from Operations	188B	271B	298B	242B	599B
Capital Expenditure	-276B	-242B	-363B	-221B	-271B
Sale of Property, Plant, and Equipment	246B	57.16B	12.24B	39.54B	43.96B
Cash Acquisitions	-77.79B	-	-6.77B	-37.62B	-8.04B
Divestitures	-141M	-	-	-	180M
Investment in Marketable and Equity Securities, Total	6.47B	6.99B	-42.42B	-57.18B	-29.28B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-3.88B	-505M	2B	2.36B	-30.03B
Other Investing Activities, Total	-25.31B	-32.13B	-24.35B	-13.27B	-27.28B
Cash from Investing	-131B	-210B	-422B	-287B	-322B
Short Term Debt Issued, Total	1,272B	1,599B	1,846B	2,535B	4,396B
Long-Term Debt Issued, Total	377B	331B	637B	861B	472B
Total Debt Issued	1,649B	1,930B	2,483B	3,396B	4,869B
Short Term Debt Repaid, Total	-1,352B	-1,583B	-1,791B	-2,486B	-4,364B
Long-Term Debt Repaid, Total	-305B	-419B	-465B	-681B	-626B
Total Debt Repaid	-1,657B	-2,003B	-2,257B	-3,168B	-4,990B
Repurchase of Common Stock	-16.83B	-30.01B	-45.01B	-21M	-42.09B
Common Dividends Paid	-42.52B	-42.33B	-59.85B	-62.55B	-87.53B
Common & Preferred Stock Dividends Paid	-42.52B	-42.33B	-59.85B	-62.55B	-87.53B
Other Financing Activities, Total	493M	5.18B	-9.89B	-105B	-18.4B
Cash from Financing	-66.56B	-140B	111B	59.99B	-269B
Foreign Exchange Rate Adjustments	17.99B	33.15B	5B	32.24B	-24.31B
Miscellaneous Cash Flow Adjustments	-	-	-2.49B	-	421M
Net Change in Cash	8.25B	-45.04B	-10.37B	46.94B	-15.98B
Supplemental Items
Cash Interest Paid	31.54B	31.44B	54.06B	74.33B	78.87B
Cash Income Tax Paid (Refund)	79.76B	90.09B	110B	90.11B	100B
Levered Free Cash Flow	-186B	-54.43B	-209B	-126B	174B
Unlevered Free Cash Flow	-169B	-34.68B	-174B	-79.58B	225B
Change In Net Working Capital	118B	57.72B	128B	205B	-123B
Net Debt Issued / Repaid	-7.71B	-72.44B	226B	228B	-121B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.68	1.92	2.24	2.32	2.41
Return on Total Capital	2.08	2.38	2.79	2.88	3.03
Return On Equity %	5.05	6.31	6.84	7.27	7.56
Return on Common Equity	5.22	6.61	6.91	7.47	7.95
Margin Analysis
Gross Profit Margin %	19.82	21.44	23.21	24.89	24.19
SG&A Margin	9.63	9.72	9.75	10.63	9.99
EBITDA Margin %	15.04	16.97	18.98	19.86	19.55
EBITA Margin %	10.15	11.66	13.46	14.25	14.2
EBIT Margin %	10.15	11.66	13.46	14.25	14.2
Income From Continuing Operations Margin %	6.46	8.37	8.96	9.55	9.37
Net Income Margin %	6.45	8.42	8.68	9.43	9.48
Net Avail. For Common Margin %	6.45	8.42	8.68	9.43	9.48
Normalized Net Income Margin	5.25	6.75	7.03	6.9	7.01
Levered Free Cash Flow Margin	-9.28	-2.59	-9.2	-5.29	6.62
Unlevered Free Cash Flow Margin	-8.41	-1.65	-7.67	-3.34	8.58
Asset Turnover
Asset Turnover	0.27	0.26	0.27	0.26	0.27
Fixed Assets Turnover	0.54	0.56	0.56	0.56	0.59
Receivables Turnover (Average Receivables)	41.78	34.65	34.6	31.44	31.98
Inventory Turnover (Average Inventory)	0.84	0.83	0.83	0.79	0.82
Short Term Liquidity
Current Ratio	2.45	2.01	1.83	2.11	1.71
Quick Ratio	0.24	0.17	0.14	0.18	0.13
Operating Cash Flow to Current Liabilities	0.19	0.21	0.2	0.17	0.32
Days Sales Outstanding (Average Receivables)	8.74	10.53	10.55	11.64	11.41
Days Outstanding Inventory (Average Inventory)	435.42	440.83	440.71	462.85	446.22
Average Days Payable Outstanding	27.16	24.17	27.86	25.56	28.25
Cash Conversion Cycle (Average Days)	416.99	427.19	423.39	448.93	429.38
Long Term Solvency
Total Debt/Equity	136.43	125.86	133.56	136.97	135.02
Total Debt / Total Capital	57.7	55.72	57.18	57.8	57.45
LT Debt/Equity	118.99	103.84	107.07	115.51	109.61
Long-Term Debt / Total Capital	50.33	45.98	45.84	48.74	46.64
Total Liabilities / Total Assets	65.69	64.5	65.72	65.91	66.83
EBIT / Interest Expense	7.34	7.75	5.51	4.56	4.53
EBITDA / Interest Expense	10.87	11.28	7.77	6.35	6.23
(EBITDA - Capex) / Interest Expense	0.92	3.64	1.23	3.39	2.94
Total Debt / EBITDA	12	10.29	9.4	9.36	8.6
Net Debt / EBITDA	11.37	9.88	9.06	8.97	8.28
Total Debt / (EBITDA - Capex)	141.37	31.91	59.57	17.54	18.27
Net Debt / (EBITDA - Capex)	133.98	30.64	57.45	16.81	17.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.35	4.65	8.01	5.03	10.16
Gross Profit, 1 Yr. Growth %	-15.29	13.2	16.92	12.62	7.08
EBITDA, 1 Yr. Growth %	-18.84	18.05	20.82	9.92	8.41
EBITA, 1 Yr. Growth %	-27.38	20.22	24.67	11.23	9.73
EBIT, 1 Yr. Growth %	-27.38	20.22	24.67	11.23	9.73
Earnings From Cont. Operations, 1 Yr. Growth %	-29.76	35.48	15.71	11.95	8.07
Net Income, 1 Yr. Growth %	-29.57	36.59	11.31	14.03	10.75
Normalized Net Income, 1 Yr. Growth %	-34.48	34.57	12.45	3.08	12.02
Diluted EPS Before Extra, 1 Yr. Growth %	-28.62	37.2	12.75	15.7	11.33
Accounts Receivable, 1 Yr. Growth %	12.18	38.68	16.22	15.09	2.4
Inventory, 1 Yr. Growth %	1.94	5.64	5.45	9.65	5.49
Net Property, Plant and Equip., 1 Yr. Growth %	1.08	3.35	9.77	1.07	6.6
Total Assets, 1 Yr. Growth %	4.69	6.02	7.72	7.33	3.9
Tangible Book Value, 1 Yr. Growth %	6.13	10	3.73	4.97	0.62
Common Equity, 1 Yr. Growth %	6.11	9.4	3.72	7.2	1.17
Cash From Operations, 1 Yr. Growth %	115.7	44.5	9.67	-18.81	147.94
Capital Expenditures, 1 Yr. Growth %	-41.68	-12.58	50.16	-39.12	22.94
Levered Free Cash Flow, 1 Yr. Growth %	-66.11	-70.78	285.17	-39.54	-237.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-68.21	-79.47	405.5	-54.27	-383.01
Dividend Per Share, 1 Yr. Growth %	0	-	12.73	35.48	10.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.86	5	6.31	6.51	7.56
Gross Profit, 2 Yr. CAGR %	-4.66	-2.08	15.05	14.75	9.81
EBITDA, 2 Yr. CAGR %	-5.92	-2.12	19.43	15.24	9.16
EBITA, 2 Yr. CAGR %	-11.83	-6.57	22.42	17.75	10.47
EBIT, 2 Yr. CAGR %	-11.83	-6.57	22.42	17.75	10.47
Earnings From Cont. Operations, 2 Yr. CAGR %	-12.68	-2.45	25.21	13.82	10
Net Income, 2 Yr. CAGR %	-12.35	-1.92	23.3	12.66	12.38
Normalized Net Income, 2 Yr. CAGR %	-18.79	-6.1	23.01	7.66	7.46
Diluted EPS Before Extra, 2 Yr. CAGR %	-11.42	-1.04	24.39	14.21	13.49
Accounts Receivable, 2 Yr. CAGR %	-0.74	24.73	31.45	15.65	8.56
Inventory, 2 Yr. CAGR %	8.88	3.77	5.55	7.53	7.55
Net Property, Plant and Equip., 2 Yr. CAGR %	4.1	2.21	6.4	5.33	3.8
Total Assets, 2 Yr. CAGR %	6.68	5.35	6.86	7.52	5.6
Tangible Book Value, 2 Yr. CAGR %	4.39	8.05	6.63	4.35	2.77
Common Equity, 2 Yr. CAGR %	4.46	7.74	6.53	5.45	4.14
Cash From Operations, 2 Yr. CAGR %	-6.89	76.55	25.89	-5.64	41.88
Capital Expenditures, 2 Yr. CAGR %	-9.62	-28.6	14.57	-4.39	-13.49
Levered Free Cash Flow, 2 Yr. CAGR %	-0.29	-68.53	-	52.6	-8.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	-0.23	-74.45	-	52.04	13.76
Dividend Per Share, 2 Yr. CAGR %	0	-	18.71	23.58	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.66	4.12	-	5.89	7.71
Gross Profit, 3 Yr. CAGR %	-1.12	0.96	-	14.23	12.13
EBITDA, 3 Yr. CAGR %	-1.51	1.47	-	16.17	12.92
EBITA, 3 Yr. CAGR %	-6.07	-2.23	-	18.57	15.02
EBIT, 3 Yr. CAGR %	-6.07	-2.23	-	18.57	15.02
Earnings From Cont. Operations, 3 Yr. CAGR %	-6.36	1.09	-	20.62	11.87
Net Income, 3 Yr. CAGR %	-5.97	1.62	-	20.13	12.02
Normalized Net Income, 3 Yr. CAGR %	-10.72	-3.9	-	15.97	9.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.19	2.49	-	21.42	13.25
Accounts Receivable, 3 Yr. CAGR %	2.27	10.96	-	25.76	11.05
Inventory, 3 Yr. CAGR %	8.27	7.79	-	6.9	6.85
Net Property, Plant and Equip., 3 Yr. CAGR %	4.64	3.85	-	4.6	5.75
Total Assets, 3 Yr. CAGR %	7.1	6.46	-	7.02	6.3
Tangible Book Value, 3 Yr. CAGR %	5.14	6.23	-	6.07	3.09
Common Equity, 3 Yr. CAGR %	5.05	6.08	-	6.75	4
Cash From Operations, 3 Yr. CAGR %	84.03	7.8	-	8.76	30.21
Capital Expenditures, 3 Yr. CAGR %	-8.44	-10.62	-	-7.2	3.97
Levered Free Cash Flow, 3 Yr. CAGR %	-12.81	-33.77	-	-10.5	47.47
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.94	-41.1	-	-20.54	87.03
Dividend Per Share, 3 Yr. CAGR %	3.23	-	-	24.05	19.14
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.07	4.27	5.32	5.07	6.62
Gross Profit, 5 Yr. CAGR %	2.41	2.61	5.05	6.26	6.22
EBITDA, 5 Yr. CAGR %	2.27	3.23	6.38	6.77	6.65
EBITA, 5 Yr. CAGR %	0.13	1.03	4.43	5.32	5.84
EBIT, 5 Yr. CAGR %	0.13	1.03	4.43	5.32	5.84
Earnings From Cont. Operations, 5 Yr. CAGR %	1.69	5.64	5.18	6	5.91
Net Income, 5 Yr. CAGR %	1.94	6.07	4.79	5.9	6.22
Normalized Net Income, 5 Yr. CAGR %	-1.3	0.92	1.49	0.57	2.74
Diluted EPS Before Extra, 5 Yr. CAGR %	2.44	6.69	5.68	7.03	7.3
Accounts Receivable, 5 Yr. CAGR %	7.27	14.54	11.57	9.49	12.9
Inventory, 5 Yr. CAGR %	10.31	8.79	6.79	7.69	5.61
Net Property, Plant and Equip., 5 Yr. CAGR %	4.73	5.46	5.57	4.63	4.51
Total Assets, 5 Yr. CAGR %	7.57	8.06	7.01	6.88	5.92
Tangible Book Value, 5 Yr. CAGR %	5.2	6.54	6.08	5.74	5.31
Common Equity, 5 Yr. CAGR %	5.86	7.1	5.64	5.83	5.48
Cash From Operations, 5 Yr. CAGR %	42.34	3.6	58.1	2.21	47.07
Capital Expenditures, 5 Yr. CAGR %	6.14	7.46	0.15	-8.18	-10.54
Levered Free Cash Flow, 5 Yr. CAGR %	0.49	-8.85	-5.32	-7.6	-20.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.36	-13.38	-7.6	-14.05	-15.77
Dividend Per Share, 5 Yr. CAGR %	7.96	-	9.16	13.81	16.15